Literature DB >> 24802527

Protective effect of curcumin against cytomegalovirus infection in Balb/c mice.

Yali Lv1, Ning Lei2, Dan Wang2, Zhuoling An1, Guangrun Li1, Feifei Han1, He Liu1, Lihong Liu3.   

Abstract

Curcumin has been found to suppress the activity of human cytomegalovirus (HCMV) in vitro, whereas its protective effects against HCMV infection in vivo remain unclear. In this study, we aimed to investigate the protective effects of curcumin against HCMV infection in Balb/c mice. Mice were randomly divided into the control, model, model+ganciclovir (positive control), and model+high-dose, model+middle-dose, and model+low-dose curcumin groups. In the model groups, each mouse was given HCMV by tail injection intravenously. Positive control animals were given ganciclovir. Animals in the curcumin treatment groups were given different concentrations of curcumin. The anti-HCMV activities of ganciclovir and curcumin were assessed by serological examination and pathology. Ganciclovir and curcumin treatment reduced the HCMV IgM level and HCMV DNA load; decreased the serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine kinase (CK), and lactate dehydrogenase (LDH) as well as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) generation in infected mice. These treatments also suppressed malondialdehyde (MDA) content and upregulated superoxide dismutase (SOD) and glutathione (GSH) levels. In addition, both treatments prevented pathological changes of the lung, kidney, liver, and heart tissues in infected mice. Our findings indicate that curcumin protected Balb/c mice against HCMV infection possibly by its anti-inflammatory and antioxidant effects.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral activity; Curcumin; Ganciclovir; Human Cytomegalovirus; inflammatory response

Mesh:

Substances:

Year:  2014        PMID: 24802527     DOI: 10.1016/j.etap.2014.04.017

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  5 in total

1.  In Vitro Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles against Feline Infectious Peritonitis Virus and Pharmacokinetics Study in Cats.

Authors:  Shing Wei Ng; Gayathri Thevi Selvarajah; Mohd Zobir Hussein; Swee Keong Yeap; Abdul Rahman Omar
Journal:  Biomed Res Int       Date:  2020-05-31       Impact factor: 3.411

Review 2.  Accelerated cancer aggressiveness by viral oncomodulation: New targets and newer natural treatments for cancer control and treatment.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2019-10-11

Review 3.  Nutraceutical Curcumin with Promising Protection against Herpesvirus Infections and Their Associated Inflammation: Mechanisms and Pathways.

Authors:  Miroslava Šudomová; Sherif T S Hassan
Journal:  Microorganisms       Date:  2021-01-31

Review 4.  Antiviral Therapeutic Potential of Curcumin: An Update.

Authors:  Abdollah Ardebili; Mohammad Hassan Pouriayevali; Sahar Aleshikh; Marziyeh Zahani; Mehdi Ajorloo; Ahdieh Izanloo; Abolghasem Siyadatpanah; Hadi Razavi Nikoo; Polrat Wilairatana; Henrique Douglas Melo Coutinho
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

Review 5.  Bioactive Effects of Curcumin in Human Immunodeficiency Virus Infection Along with the Most Effective Isolation Techniques and Type of Nanoformulations.

Authors:  Monica Butnariu; Cristina Quispe; Niranjan Koirala; Sujan Khadka; Carla Marina Salgado-Castillo; Muhammad Akram; Rabia Anum; Balakyz Yeskaliyeva; Natália Cruz-Martins; Miquel Martorell; Manoj Kumar; Radu Vasile Bagiu; Ahmad Faizal Abdull Razis; Usman Sunusi; Ramla Muhammad Kamal; Javad Sharifi-Rad
Journal:  Int J Nanomedicine       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.